Cholecystokinin-induced pancreatic growth involves the high-affinity CCK receptor and concomitant activation of tyrosine kinase and phospholipase D

Ann N Y Acad Sci. 1994 Mar 23:713:422-3. doi: 10.1111/j.1749-6632.1994.tb44114.x.
No abstract available

MeSH terms

  • Animals
  • Ceruletide / administration & dosage
  • Ceruletide / pharmacology*
  • DNA / metabolism
  • Enzyme Activation
  • Infusions, Intravenous
  • Male
  • Organ Size / drug effects
  • Pancreas / drug effects
  • Pancreas / enzymology
  • Pancreas / physiology*
  • Phospholipase D / metabolism*
  • Protein-Tyrosine Kinases / metabolism*
  • Proteins / metabolism
  • RNA / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Cholecystokinin / antagonists & inhibitors
  • Receptors, Cholecystokinin / physiology*
  • Sincalide / administration & dosage
  • Sincalide / analogs & derivatives*
  • Sincalide / pharmacology

Substances

  • Proteins
  • Receptors, Cholecystokinin
  • JMV 180
  • RNA
  • Ceruletide
  • DNA
  • Protein-Tyrosine Kinases
  • Phospholipase D
  • Sincalide